A survey of developments in food and drug law from July 1998 to November 1999.
作者信息
Littlefield N, Hada N R
机构信息
Foley, Hoag & Eliot, Boston, MA, USA.
出版信息
Food Drug Law J. 2000;55(1):35-56.
PMID:12296348
Abstract
摘要
相似文献
1
A survey of developments in food and drug law from July 1998 to November 1999.1998年7月至1999年11月食品与药品法发展情况调查。
Food Drug Law J. 2000;55(1):35-56.
2
The FDA at work: cutting-edge science promoting public health.美国食品药品监督管理局在行动：前沿科学推动公众健康。
FDA Consum. 2006 Jan-Feb;40(1):28-35, 39-41.
3
Entry decisions in the generic pharmaceutical industry.仿制药行业的进入决策
Rand J Econ. 1999 Fall;30(3):421-40.
4
Drug marketing exclusivity under United States and European Union law.美国和欧盟法律下的药品市场独占权。
Food Drug Law J. 2004;59(4):479-518.
5
FDA milestones.美国食品药品监督管理局的里程碑事件。
FDA Consum. 2006 Jan-Feb;40(1):36-8.
6
7
Changing requirements for evaluation of pharmacologic agents.药物评估要求的不断变化。
Pediatrics. 2004 Apr;113(4 Suppl):1128-32.
8
The food and drug legislation of 1906.1906年的食品药品立法。
Mol Interv. 2008 Feb;8(1):4-11. doi: 10.1124/mi.8.1.2.
9
The right to a trial: Should dying patients have access to experimental drugs?审判权：临终患者是否应有权使用实验性药物？
New Yorker. 2006 Dec 18:40-7.
10
Teaching clinicians about drugs--50 years later, whose job is it?50年后，向临床医生传授药物知识，这是谁的职责？
N Engl J Med. 2011 Mar 31;364(13):1185-7. doi: 10.1056/NEJMp1011713.
Zotero 插件